NCT02398201View on ClinicalTrials.gov

A Study of Bezafibrate in Mitochondrial Myopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

March 23, 2017

Conditions
Mitochondrial Diseases
Interventions
DRUG

Bezafibrate

Bezafibrate 200mg-600mg three times daily for 12 weeks.

Trial Locations (1)

NE1 4LP

Clinical Research Facility, Royal Victoria Infirmary, Newcastle upon Tyne

All Listed Sponsors
collaborator

Newcastle University

OTHER

lead

Newcastle-upon-Tyne Hospitals NHS Trust

OTHER

NCT02398201 - A Study of Bezafibrate in Mitochondrial Myopathy | Biotech Hunter | Biotech Hunter